LY3009385

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3009385, covering 2014-10-06 to 2014-10-06. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Study of LY3009385 in Healthy Participants [Phase 1]